236 related articles for article (PubMed ID: 17360815)
41. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
42. Regulation of the human SOX9 promoter by Sp1 and CREB.
Piera-Velazquez S; Hawkins DF; Whitecavage MK; Colter DC; Stokes DG; Jimenez SA
Exp Cell Res; 2007 Apr; 313(6):1069-79. PubMed ID: 17289023
[TBL] [Abstract][Full Text] [Related]
43. Negative correlation between Per1 and Sox6 expression during chondrogenic differentiation in pre-chondrocytic ATDC5 cells.
Le NQ; Binh NT; Takarada T; Takarada-Iemata M; Hinoi E; Yoneda Y
J Pharmacol Sci; 2013; 122(4):318-25. PubMed ID: 23883486
[TBL] [Abstract][Full Text] [Related]
44. Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9.
Zhang P; Jimenez SA; Stokes DG
J Biol Chem; 2003 Jan; 278(1):117-23. PubMed ID: 12399468
[TBL] [Abstract][Full Text] [Related]
45. [Sox family regulate chondrogenesis].
Akiyama H
Clin Calcium; 2006 Feb; 16(2):368- 72. PubMed ID: 16465043
[TBL] [Abstract][Full Text] [Related]
46. [Transcriptional regulation in chondrogenesis by Sox9].
Akiyama H
Clin Calcium; 2011 Jun; 21(6):845-51. PubMed ID: 21628799
[TBL] [Abstract][Full Text] [Related]
47. Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation.
Muramatsu S; Wakabayashi M; Ohno T; Amano K; Ooishi R; Sugahara T; Shiojiri S; Tashiro K; Suzuki Y; Nishimura R; Kuhara S; Sugano S; Yoneda T; Matsuda A
J Biol Chem; 2007 Nov; 282(44):32158-67. PubMed ID: 17804410
[TBL] [Abstract][Full Text] [Related]
48. Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line.
Locker M; Kellermann O; Boucquey M; Khun H; Huerre M; Poliard A
J Bone Miner Res; 2004 Jan; 19(1):100-10. PubMed ID: 14753742
[TBL] [Abstract][Full Text] [Related]
49. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
[TBL] [Abstract][Full Text] [Related]
50. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination.
Bernard P; Tang P; Liu S; Dewing P; Harley VR; Vilain E
Hum Mol Genet; 2003 Jul; 12(14):1755-65. PubMed ID: 12837698
[TBL] [Abstract][Full Text] [Related]
51. Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription.
Amano K; Hata K; Muramatsu S; Wakabayashi M; Takigawa Y; Ono K; Nakanishi M; Takashima R; Kogo M; Matsuda A; Nishimura R; Yoneda T
Mol Biol Cell; 2011 Apr; 22(8):1300-11. PubMed ID: 21346191
[TBL] [Abstract][Full Text] [Related]
52. Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins.
McMahon S; Grondin F; McDonald PP; Richard DE; Dubois CM
J Biol Chem; 2005 Feb; 280(8):6561-9. PubMed ID: 15611046
[TBL] [Abstract][Full Text] [Related]
53. Dexamethasone enhances SOX9 expression in chondrocytes.
Sekiya I; Koopman P; Tsuji K; Mertin S; Harley V; Yamada Y; Shinomiya K; Nifuji A; Noda M
J Endocrinol; 2001 Jun; 169(3):573-9. PubMed ID: 11375127
[TBL] [Abstract][Full Text] [Related]
54. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.
Otero M; Peng H; Hachem KE; Culley KL; Wondimu EB; Quinn J; Asahara H; Tsuchimochi K; Hashimoto K; Goldring MB
Connect Tissue Res; 2017 Jan; 58(1):15-26. PubMed ID: 27310669
[TBL] [Abstract][Full Text] [Related]
55. A new chondrogenic differentiation initiator with the ability to up-regulate SOX trio expression.
Noguchi K; Watanabe Y; Fuse T; Takizawa M
J Pharmacol Sci; 2010; 112(1):89-97. PubMed ID: 20051655
[TBL] [Abstract][Full Text] [Related]
56. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo.
Yoon BS; Ovchinnikov DA; Yoshii I; Mishina Y; Behringer RR; Lyons KM
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5062-7. PubMed ID: 15781876
[TBL] [Abstract][Full Text] [Related]
57. S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes.
Saito T; Ikeda T; Nakamura K; Chung UI; Kawaguchi H
EMBO Rep; 2007 May; 8(5):504-9. PubMed ID: 17396138
[TBL] [Abstract][Full Text] [Related]
58. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements.
Bridgewater LC; Walker MD; Miller GC; Ellison TA; Holsinger LD; Potter JL; Jackson TL; Chen RK; Winkel VL; Zhang Z; McKinney S; de Crombrugghe B
Nucleic Acids Res; 2003 Mar; 31(5):1541-53. PubMed ID: 12595563
[TBL] [Abstract][Full Text] [Related]
59. Sox9 and p300 cooperatively regulate chromatin-mediated transcription.
Furumatsu T; Tsuda M; Yoshida K; Taniguchi N; Ito T; Hashimoto M; Ito T; Asahara H
J Biol Chem; 2005 Oct; 280(42):35203-8. PubMed ID: 16109717
[TBL] [Abstract][Full Text] [Related]
60. The orphan nuclear estrogen receptor-related receptor-alpha regulates cartilage formation in vitro: implication of Sox9.
Bonnelye E; Zirngibl RA; Jurdic P; Aubin JE
Endocrinology; 2007 Mar; 148(3):1195-205. PubMed ID: 17170100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
